Further characterization of NOTCH1 across large cohorts of ESCC may identify a subgroup of ESCC with an oncogenic role of NOTCH1, which can be treated with NOTCH1 pathway inhibitors. The gene discussed is NOTCH1; the disease is esophageal squamous cell carcinoma.